These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37539328)

  • 1. Mismatch negativity generation in subjects at risk for psychosis: source analysis is more sensitive than surface electrodes in risk prediction.
    Aeberli T; Müller M; Theodoridou A; Hagenmuller F; Seifritz E; Walitza S; Rössler W; Kawohl W; Heekeren K
    Front Psychiatry; 2023; 14():1130809. PubMed ID: 37539328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mismatch negativity: Alterations in adults from the general population who report subclinical psychotic symptoms.
    Döring C; Müller M; Hagenmuller F; Ajdacic-Gross V; Haker H; Kawohl W; Rössler W; Heekeren K
    Eur Psychiatry; 2016 Apr; 34():9-16. PubMed ID: 26928341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch Negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis.
    Solís-Vivanco R; Mondragón-Maya A; León-Ortiz P; Rodríguez-Agudelo Y; Cadenhead KS; de la Fuente-Sandoval C
    Schizophr Res; 2014 Sep; 158(1-3):58-63. PubMed ID: 25064664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis.
    Nagai T; Tada M; Kirihara K; Yahata N; Hashimoto R; Araki T; Kasai K
    Schizophr Res; 2013 Nov; 150(2-3):547-54. PubMed ID: 24012461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis.
    Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrión RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
    JAMA Psychiatry; 2022 Aug; 79(8):780-789. PubMed ID: 35675082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
    Koshiyama D; Kirihara K; Tada M; Nagai T; Koike S; Suga M; Araki T; Kasai K
    Schizophr Res; 2017 Dec; 190():32-38. PubMed ID: 28314681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis.
    Atkinson RJ; Michie PT; Schall U
    Biol Psychiatry; 2012 Jan; 71(2):98-104. PubMed ID: 22000060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.
    Perez VB; Woods SW; Roach BJ; Ford JM; McGlashan TH; Srihari VH; Mathalon DH
    Biol Psychiatry; 2014 Mar; 75(6):459-69. PubMed ID: 24050720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.
    Lavoie S; Jack BN; Griffiths O; Ando A; Amminger P; Couroupis A; Jago A; Markulev C; McGorry PD; Nelson B; Polari A; Yuen HP; Whitford TJ
    Schizophr Res; 2018 Jan; 191():95-100. PubMed ID: 29132815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis.
    Fujioka M; Kirihara K; Koshiyama D; Tada M; Nagai T; Usui K; Morita S; Kawakami S; Morita K; Satomura Y; Koike S; Suga M; Araki T; Kasai K
    Front Psychiatry; 2020; 11():770. PubMed ID: 32848939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis.
    Murphy JR; Rawdon C; Kelleher I; Twomey D; Markey PS; Cannon M; Roche RA
    BMC Psychiatry; 2013 Feb; 13():45. PubMed ID: 23375130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
    Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
    Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the duration and frequency of deviant stimuli engender different mismatch negativity patterns in temporal lobe epilepsy.
    Hirose Y; Hara K; Miyajima M; Matsuda A; Maehara T; Hara M; Matsushima E; Ohta K; Matsuura M
    Epilepsy Behav; 2014 Feb; 31():136-42. PubMed ID: 24412859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review.
    Nagai T; Tada M; Kirihara K; Araki T; Jinde S; Kasai K
    Front Psychiatry; 2013 Sep; 4():115. PubMed ID: 24069006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between mismatch negativity and global functioning is specific to duration deviance in early stages of psychosis.
    Koshiyama D; Kirihara K; Tada M; Nagai T; Fujioka M; Koike S; Suga M; Araki T; Kasai K
    Schizophr Res; 2018 May; 195():378-384. PubMed ID: 28986006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Rydkjær J; Møllegaard Jepsen JR; Pagsberg AK; Fagerlund B; Glenthøj BY; Oranje B
    Psychol Med; 2017 Jan; 47(2):377-388. PubMed ID: 27776572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity.
    Kim M; Lee TH; Yoon YB; Lee TY; Kwon JS
    Schizophr Bull; 2018 Apr; 44(3):575-583. PubMed ID: 29036493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant temporal behavior of mismatch negativity generators in schizophrenia patients and subjects at clinical high risk for psychosis.
    Kim M; Cho KI; Yoon YB; Lee TY; Kwon JS
    Clin Neurophysiol; 2017 Feb; 128(2):331-339. PubMed ID: 28056388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact Mismatch Negativity Responses in Clinical High Risk for Psychosis and First-Episode Psychosis: Evidence From Source-Reconstructed Event-Related Fields and Time-Frequency Data.
    Dheerendra P; Grent-'t-Jong T; Gajwani R; Gross J; Gumley AI; Krishnadas R; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jan; 9(1):121-131. PubMed ID: 37778724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
    Fisher DJ; Labelle A; Knott VJ
    Schizophr Res; 2012 Aug; 139(1-3):237-45. PubMed ID: 22727705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.